Sign in

CIK 0001453687

  • Non-accelerated filer
  • Smaller reporting company

Cartesian Therapeutics, Inc.

Sign in to watch
Ticker
RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-348-8698
Business address
7495 NEW HORIZON WAY, FREDERICK, MD, 21703
Former names
SELECTA BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-11-13 BARABE TIMOTHY C Director Returned to the company · Stock Option (Right to Buy) −40,000 0
2023-11-13 BARABE TIMOTHY C Director Returned to the company · Stock Option (Right to Buy) −40,000 0
2023-11-13 BARABE TIMOTHY C Director Returned to the company · Stock Option (Right to Buy) −87,500 $0.93 $81K 0
2023-11-13 COX CARRIE SMITH Director Returned to the company · Stock Option (Right to Buy) −20,000 $0.74 $15K 0
2023-11-13 COX CARRIE SMITH Director Returned to the company · Stock Option (Right to Buy) −30,000 0
2023-11-13 COX CARRIE SMITH Director Returned to the company · Stock Option (Right to Buy) −60,000 0
2023-11-13 COX CARRIE SMITH Director Returned to the company · Stock Option (Right to Buy) −60,000 0
2023-11-13 COX CARRIE SMITH Director Returned to the company · Stock Option (Right to Buy) −107,500 $0.93 $100K 0
2023-11-13 Kurtoglu Metin Chief Operations Officer Grant or award · Stock Option (Right to Buy) +6,414.68 6,414.68
2023-11-13 Kurtoglu Metin Chief Operations Officer Grant or award · Stock Option (Right to Buy) +427.65 427.65
2023-11-13 Kurtoglu Metin Chief Operations Officer Grant or award · Stock Option (Right to Buy) +427.65 427.65
2023-11-13 Jewell Christopher M Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +4,276.45 4,276.45
2023-11-13 Singer Michael Director Grant or award +110,123 110,123
2023-11-13 Singer Michael Director Other acquisition +197,663 197,663
2023-11-13 Singer Michael Director Other acquisition +29,212 29,212
2023-11-13 Singer Michael Director Other acquisition +3,670 3,670
2023-11-13 Singer Michael Director Other acquisition +49,555 49,555
2023-11-13 Singer Michael Director Other acquisition +49,555 49,555
2023-11-13 Singer Michael Director Other acquisition +7,616 7,616
2023-11-13 Singer Michael Director Grant or award · Series A Non-Voting Convertible Preferred Stock +6,304.56 6,304.56

Page 17 of 25 · 495 trades